144 related articles for article (PubMed ID: 34358678)
1. Transcriptome Analysis Identifies GATA3-AS1 as a Long Noncoding RNA Associated with Resistance to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients.
Contreras-Espinosa L; Alcaraz N; De La Rosa-Velázquez IA; Díaz-Chávez J; Cabrera-Galeana P; Rebollar-Vega R; Reynoso-Noverón N; Maldonado-Martínez HA; González-Barrios R; Montiel-Manríquez R; Bautista-Sánchez D; Castro-Hernández C; Alvarez-Gomez RM; Jiménez-Trejo F; Tapia-Rodríguez M; García-Gordillo JA; Pérez-Rosas A; Bargallo-Rocha E; Arriaga-Canon C; Herrera LA
J Mol Diagn; 2021 Oct; 23(10):1306-1323. PubMed ID: 34358678
[TBL] [Abstract][Full Text] [Related]
2.
Mitobe Y; Ikeda K; Suzuki T; Takagi K; Kawabata H; Horie-Inoue K; Inoue S
Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31501276
[TBL] [Abstract][Full Text] [Related]
3. LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway.
Zhang M; Wang Y; Jiang L; Song X; Zheng A; Gao H; Wei M; Zhao L
J Exp Clin Cancer Res; 2021 Jan; 40(1):41. PubMed ID: 33494806
[TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNA GATA3-AS1 Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Suppression of PTEN, CDKN1A, and TP53.
Luo X; Zhou N; Wang L; Zeng Q; Tang H
Can J Gastroenterol Hepatol; 2019; 2019():1389653. PubMed ID: 31871924
[TBL] [Abstract][Full Text] [Related]
5. Low Expression of Long Noncoding RNA SLC26A4 Antisense RNA 1 Is an Independent Prognostic Biomarker and Correlate of Immune Infiltrates in Breast Cancer.
Yi W; Shen H; Sun D; Xu Y; Feng Y; Li D; Wang C
Med Sci Monit; 2021 Dec; 27():e934522. PubMed ID: 34880202
[TBL] [Abstract][Full Text] [Related]
6. LncRNA GNAS-AS1 facilitates ER+ breast cancer cells progression by promoting M2 macrophage polarization via regulating miR-433-3p/GATA3 axis.
Liu SQ; Zhou ZY; Dong X; Guo L; Zhang KJ
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32538432
[TBL] [Abstract][Full Text] [Related]
7. Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer.
Jacquemier J; Charafe-Jauffret E; Monville F; Esterni B; Extra JM; Houvenaeghel G; Xerri L; Bertucci F; Birnbaum D
Breast Cancer Res; 2009; 11(2):R23. PubMed ID: 19405945
[TBL] [Abstract][Full Text] [Related]
8. LncRNA GATA3-AS1 facilitates tumour progression and immune escape in triple-negative breast cancer through destabilization of GATA3 but stabilization of PD-L1.
Zhang M; Wang N; Song P; Fu Y; Ren Y; Li Z; Wang J
Cell Prolif; 2020 Sep; 53(9):e12855. PubMed ID: 32687248
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA lnc-LOC645166 promotes adriamycin resistance via NF-κB/GATA3 axis in breast cancer.
Zheng R; Jia J; Guan L; Yuan H; Liu K; Liu C; Ye W; Liao Y; Lin S; Huang O
Aging (Albany NY); 2020 May; 12(10):8893-8912. PubMed ID: 32461377
[TBL] [Abstract][Full Text] [Related]
10. MiR-6872 host gene SEMA3B and its antisense lncRNA SEMA3B-AS1 function synergistically to suppress gastric cardia adenocarcinoma progression.
Guo W; Liang X; Liu L; Guo Y; Shen S; Liang J; Dong Z
Gastric Cancer; 2019 Jul; 22(4):705-722. PubMed ID: 30656427
[TBL] [Abstract][Full Text] [Related]
11. Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer.
Bayarmaa B; Wu Z; Peng J; Wang Y; Xu S; Yan T; Yin W; Lu J; Zhou L
BMC Cancer; 2019 Sep; 19(1):877. PubMed ID: 31488093
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic Analysis of Breast Cancer Patients Sensitive and Resistant to Chemotherapy: Looking for Overall Survival and Drug Resistance Biomarkers.
Barrón-Gallardo CA; Garcia-Chagollán M; Morán-Mendoza AJ; Delgadillo-Cristerna R; Martínez-Silva MG; Aguilar-Lemarroy A; Jave-Suárez LF
Technol Cancer Res Treat; 2022; 21():15330338211068965. PubMed ID: 34981997
[TBL] [Abstract][Full Text] [Related]
13. Assessment of expression of interferon γ (IFN-G) gene and its antisense (IFNG-AS1) in breast cancer.
Yaghoobi H; Azizi H; Oskooei VK; Taheri M; Ghafouri-Fard S
World J Surg Oncol; 2018 Oct; 16(1):211. PubMed ID: 30336781
[TBL] [Abstract][Full Text] [Related]
14. Functional Role of a Novel Long Noncoding RNA
Lin C; Zhang S; Wang Y; Wang Y; Nice E; Guo C; Zhang E; Yu L; Li M; Liu C; Hu L; Hao J; Qi W; Xu H
Clin Cancer Res; 2018 Jan; 24(2):486-498. PubMed ID: 29101304
[No Abstract] [Full Text] [Related]
15. Divergent lncRNA
Gibbons HR; Shaginurova G; Kim LC; Chapman N; Spurlock CF; Aune TM
Front Immunol; 2018; 9():2512. PubMed ID: 30420860
[TBL] [Abstract][Full Text] [Related]
16. A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients.
Risi E; Grilli A; Migliaccio I; Biagioni C; McCartney A; Guarducci C; Bonechi M; Benelli M; Vitale S; Biganzoli L; Bicciato S; Di Leo A; Malorni L
Breast Cancer Res Treat; 2018 Jul; 170(2):329-341. PubMed ID: 29564743
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
18. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
Huang W; Liu Z; Li Y; Liu L; Mai G
J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
[TBL] [Abstract][Full Text] [Related]
19. A nine-lncRNA signature predicts distant relapse-free survival of HER2-negative breast cancer patients receiving taxane and anthracycline-based neoadjuvant chemotherapy.
Sun M; Liu X; Xia L; Chen Y; Kuang L; Gu X; Li T
Biochem Pharmacol; 2021 Jul; 189():114285. PubMed ID: 33069665
[TBL] [Abstract][Full Text] [Related]
20. LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway.
Fang K; Hu C; Zhang X; Hou Y; Gao D; Guo Z; Li L
Carcinogenesis; 2020 Sep; 41(9):1273-1281. PubMed ID: 31784750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]